By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market on Wednesday that its second-quarter revenues climbed 17 percent year over year on the strength of its US breast cancer business and growth internationally.

For the three months ended June 30, the Redwood City, Calif., company said revenues reached $50.8 million, up from $43.4 million a year ago, short of Wall Street estimates of $50.9 million in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.